MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Biospace.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Biospace.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Biospace.com most likely does not offer any adult content.
Audience
-
Bounce rate
-
Time on site
03:45
AVG
-
Gender
Men
37%
Women
67%
Popular pages
-
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring
Medtronic AccuRhythm AI technology receives 2023 MedTech Breakthrough Award as Best New Monitoring Solution - read this article along with other careers information, tips and advice on BioSpace
-
NervGen Pharma Reports Q1 2023 Results and Provides Operational Update Including Clinical Trials of
NervGen Pharma Corp. (TSXV: NGEN) (OTCQX: NGENF) ("NervGen" or the "Company"), a clinical stage biotech company dedicated to developing innovative solutions for the treatment of nervous system damage...
-
Cara Therapeutics Reports First Quarter 2023 Financial Results | BioSpace
Cara Therapeutics Reports First Quarter 2023 Financial Results - read this article along with other careers information, tips and advice on BioSpace
-
Abivax Announces its Ordinary and Extraordinary General Meeting of June 5, 2023, and the
Abivax Announces its Ordinary and Extraordinary General Meeting of June 5, 2023, and the Availability of the Preparatory Documents - read this article along with other careers information, tips and ad...
-
StageZero to Issue Q1 2023 Financial Results After Market Closes May 15, 2023 | BioSpace
StageZero Life Sciences (TSX: SZLS) ("StageZero" or the "Company") today announced that it will release its first quarter 2023 operational results after the market closes on Monday May 15, 2023.
-
BioSpace: Biotech, Pharmaceutical and Clinical Research News
Drop In FDA Approvals (And New Administration) Rekindles Fears For The Future Of Pharma